Company Overview and News

 
D-Street Buzz: Nifty metal outperforms led by JSW Steel; Dish TV down 6%, BoB most active

18h moneycontrol
The Indian benchmark indices continues to trade on a positive note this Wednesday afternoon with the Nifty50 up 21 points and is trading at 11,300 while the Sensex is trading higher by 53 points at 37,343.
HINDCOPPER KOHINOOR MUTHOOTFIN PGEL 500325 500228 RELIANCE 532617 HNDZY HFCL 533398 NAUKRI 532777 533137 HCL-INSYS DEN 532221 500470 SONATSOFTW RIGD 500179 JSL GAILF BEL RLNIY SBAZ BHQRY HINDALCO 532508 533581 513599 JETAIRWAYS JSWSTEEL 533104 512559 HNDNF 500183 TTST TATASTEEL TATLY GAILY DCMSHRIRAM 500049 GLOBUSSPR 500440 500188 HINDZINC 523367

 
The Sleeping Tigers: A Revival Story by Rana Som-Review

2018-09-02 freepressjournal.in
There are two books in this one book. Both the books are exciting and credit goes to the author Rana Som. Rana Som served as the Chairman-cum-Managing Director (CMD) of Hindustan Copper Ltd (HCL) and National Mineral Development Corporation Ltd. (NMDC). If he would have served in a private enterprise by this time he would have been the darling of media and regarded as the best turnaround man. The book is a shining example of the suffering of public sector units and its employees.
HINDCOPPER 513599

3
D-Street Buzz: Metal stocks shine with Tata Steel JSPL up 2-4%; ITI zooms 14%

2018-08-30 moneycontrol
The Sensex and the Nifty managed to regain some lost ground this Thursday afternoon with the Nifty50 down 12 points at 11,679 while the Sensex is down 22 points at 38,700.34
HINDCOPPER AMKD 500325 532939 UDBKL 500228 RELIANCE UBLS AMTEKAUTO 511389 VIDEOIND CADILAHC 532321 500470 RIGD UBLA GAILF RLNIY YESBANK RPOWER 513599 532648 YYBKY JSWSTEEL CDLYY BRK.A TTST TATASTEEL TATLY GAILY 501455 520077 GREAVESCOT

 
Hindustan Copper Ltd - AGM/Book Closure

2018-08-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HINDCOPPER 513599

 
Hindustan Copper Ltd - Updates

2018-08-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HINDCOPPER 513599

 
Hindustan Copper Ltd - Shareholders meeting

2018-08-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HINDCOPPER 513599

 
Hindustan Copper Ltd - Change in Auditors

2018-08-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HINDCOPPER 513599

 
Govt turns to power sector to meet divestment target: Report

2018-08-20 moneycontrol
The government is eyeing the power sector to buy out its stake in companies and meet its divestment target, The Times of India reports.
HINDCOPPER 513599 HINDPETRO 500104

 
D-Street Buzz: Pharma, FMCG stocks gain led by Cadila Health ITC; Infosys hits new record high

2018-08-17 moneycontrol
The Indian benchmark indices this Friday morning are trading on a bullish note with the Nifty jumping 66 points at 11, 451 while the Sensex rallied 244 points and is trading at 37,907.
HINDCOPPER AUROPHARMA 500228 UBL HNDZY 511389 VIDEOIND 532478 CADILAHC 535789 532321 500470 533207 506690 UNICHEMLAB HINDALCO 524804 IDKQY UBHOLDINGS 513599 CANFINHOME 511196 UNBWY JSWSTEEL CDLYY VTL IBULHSGFIN HNDNF TTST BATAINDIA TATASTEEL JPINFRATEC TATLY ARBQY 502986 507458 500043 500440 500188 HINDZINC

 
Hindustan Copper eyes ₹10,000 crore turnover by FY24

2018-08-11 livemint
Mumbai: State-run Hindustan Copper is looking to achieve a turnover of ₹10,000 crore by financial year 2023-24 through capacity expansion, a top company official said.
HINDCOPPER 513599

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...